Aldeyra Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALDX and other ETFs, options, and stocks.About ALDX
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases.
CEOTodd C. Brady
CEOTodd C. Brady
Employees9
Employees9
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded2004
Founded2004
Employees9
Employees9
ALDX Key Statistics
Market cap287.28M
Market cap287.28M
Price-Earnings ratio-6.64
Price-Earnings ratio-6.64
Dividend yield—
Dividend yield—
Average volume1.19M
Average volume1.19M
High today$5.02
High today$5.02
Low today$4.77
Low today$4.77
Open price$4.94
Open price$4.94
Volume1.70M
Volume1.70M
52 Week high$7.20
52 Week high$7.20
52 Week low$1.14
52 Week low$1.14
Stock Snapshot
As of today, Aldeyra Therapeutics(ALDX) shares are valued at $4.77. The company's market cap stands at 287.28M, with a P/E ratio of -6.64.
During the trading session on 2025-12-10, Aldeyra Therapeutics(ALDX) shares reached a daily high of $5.02 and a low of $4.77. At a current price of $4.77, the stock is +0.0% higher than the low and still -5.0% under the high.
Trading activity shows a volume of 1.7M, compared to an average daily volume of 1.19M.
The stock's 52-week range extends from a low of $1.14 to a high of $7.20.
The stock's 52-week range extends from a low of $1.14 to a high of $7.20.
People also own
Based on the portfolios of people who own ALDX. This list is generated using Robinhood data, and it’s not a recommendation.